{"id":"W2531697186","doi":"10.1182/blood.v124.21.377.377","title":"Gemtuzumab Ozogamicin (GO) in Infants with Acute Myeloid Leukemia (AML) – Combined Results from the Children’s Oncology Group (COG) Trials, AAML03P1 and AAML0531","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Internal medicine; Leukemia; Induction chemotherapy; Myeloid leukemia; Juvenile myelomonocytic leukemia; Acute promyelocytic leukemia; Pediatrics; Clinical trial; Chemotherapy; Oncology; Surgery; Stem cell; CD33; CD34","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002385991,0.0005556936,0.001438388,0.0003804532,0.0002521487,0.0007920163,0.0005218302,0.0006995798,0.001177076],"category_scores_gemma":[0.001559024,0.0002515403,0.001319554,0.0004667213,0.0003423868,0.0004840476,0.0003708701,0.00131296,0.0001831159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009369449,"about_ca_system_score_gemma":0.001369774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001397847,"about_ca_topic_score_gemma":0.005251015,"domain_scores_codex":[0.9991682,0.0005611336,0.00006549817,0.0000571899,0.0000663489,0.0000817372],"domain_scores_gemma":[0.9990728,0.0003288343,0.000229489,0.00004459441,0.00005482476,0.0002694981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7869468,0.003619632,0.01310549,0.002888895,0.005157928,0.0002228278,0.0001590431,0.002855808,0.006434947,0.0005693993,0.009384234,0.1686549],"study_design_scores_gemma":[0.6887634,0.1913786,0.07548664,0.0008907595,0.01038225,0.0008829207,0.0001410991,0.002354306,0.005120232,0.0009198639,0.0236126,0.00006724489],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9560888,0.03604081,0.0002590806,0.001410413,0.0002415906,0.001172784,0.001761941,0.00005217678,0.002972492],"genre_scores_gemma":[0.9824964,0.01087713,0.001393044,0.0008237252,0.000241675,0.001269585,0.002093999,0.0000109381,0.0007935108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002385991,"threshold_uncertainty_score":0.01261848,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0190846756743633,"score_gpt":0.2848237912399462,"score_spread":0.2657391155655829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}